Summary
The control of hexokinase activity probably is accomplished by regulating the partitioning of the enzyme between soluble and particulate forms, the latter being more active. In the present investigation we have examined the thiopental effect on the cerebral hexokinase distribution. In anesthesia, after administration of thiopental to male Sprague Dawley rats, the increase of the soluble fraction of hexokinase was dose dependent.
The change in the intracellular hexokinase distribution was reversible and lasted as long as general anesthesia existed.
Also in experiments in vitro a solubilization of the mitochondrial hexokinase by thiopental (0.1–1 mM) occurred; it was depending on drug concentration. An inhibition of hexokinase was found neither in the total brain extract, nor in the soluble or the particulate fraction. The results suggest that phosphorylation of glucose in brain may be suppressed in anesthesia by shifting hexokinase activity from a more active mitochondrial form to its less active soluble form.
This effect seems to be caused by a direct action of thiopental and is obviously correlated with anesthesia.
Similar content being viewed by others
References
Biebuyck, J. F., Hawkins, R. A.: The effect of anesthetic agents on brain tissue metabolic patterns. Brit. J. Anaesth. 44, 226–227 (1972)
Bielicki, L., Krieglstein, J.: Inhibition of glucose phosphorylation in rat brain by thiopental. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, 25–29 (1976)
Brunner, E. A., Passonneau, J. V., Molstad, C.: The effect of volatile anaesthetics on levels of metabolites and on metabolic rate in brain. J. Neurochem. 18, 2301–2316 (1971)
Carlsson, C., Harp, J. R., Siesjö, B. K.: Metabolic changes in the cerebral cortex of the rat reduced by intravenous pentothalsodium. Acta anaesth. scand. 57, 7–17 (1975)
Craven, P. A., Basford, R. E.: Brain hexokinase: Immunohistochemical localisation at the light microscopic level. Biochemistry 8, 3520–3525 (1969)
Gatfield, P. D., Lowry, O. H., Schulz, D. W., Passonneau, J. V.: Regional energy reserves in mouse brain and changes with ischemia and anesthesia. J. Neurochem. 13, 185–195 (1966)
Gey, K. F., Rutishauser, M., Pletscher, A.: Suppression of glycolysis in rat brain in vivo by chlorpromazine, reserpine and phenobarbital. Biochem. Pharmacol. 14, 507–514 (1965)
Guenther, W. C.: Analysis of variance. Englewood Cliffs, N.Y.: Prentice-Hall 1964
Hein, H., Krieglstein, J., Stock, R.: The effects of increased glucose supply and thiopental anesthesia on energy metabolism of the isolated perfused rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 289, 399–407 (1975)
Hernandez, A., Crane, R. K.: Association of heart hexokinase with subcellular structure. Arch. Biochem. Biophys. 113, 223–229 (1966)
Karpatkin, S.: Soluble and particulate hexokinase of frog skeletal muscle. J. biol. Chem. 242, 3525–3530 (1967)
Knull, H. R., Taylor, W. F., Wells, W. W.: Effects of energy metabolism on in vivo distribution of hexokinase in brain. J. biol. Chem. 218, 5414–5417 (1973)
Knull, H. R., Taylor, W. F., Wells, W. W.: Insulin effects on brain energy metabolism and the related hexokinase distribution. J. biol. Chem. 249, 6930–6935 (1974)
Kosow, D. P., Rose, I. A.: Ascites tumor mitochondrial hexokinase II: effect of binding on kinetic properties. J. biol. Chem. 243, 3623–3630 (1968)
Krieglstein, J., Bielicki, L.: The influence of thiopental on the intracellular distribution of hexokinase in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, R11 (1976)
Krieglstein, J., Stock, R.: Comparative study of the effects of chloral hydrate and trichloroethanol on cerebral metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 323–332 (1973)
Krieglstein, J., Stock, R.: The isolated perfused rat brain as a model for studying drugs acting on the CNS. Psychopharmacologia (Berl.) 35, 169–177 (1974)
Krieglstein, J., Stock, R.: Energy metabolism of the isolated perfused rat brain as influenced by anesthetics. Biochem. Pharmacol. 24, 1579–1582 (1975)
Kropp, E. S., Wilson, J. E.: Hexokinase binding sites on mitochondrial membranes. Biochem. biophys. Res. Commun. 38, 74–79 (1970)
Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., Schulz, D. W.: Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J. biol. Chem. 239, 18–30 (1964)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Mark, L. C., Burns, J. J., Campomanes, C. I., Ngai, S. H., Trousof, N., Papper, E. M., Brodie, B. B.: The passage of thiopental into brain. J. Pharmacol. exp. Ther. 119, 35–38 (1957)
Mayman, C. I., Gatfield, P. D., Breckenridge, B. McL.: The glucose content of brain in anesthesia. J. Neurochem. 11, 483–487 (1964)
McIlwain, H., Bachelard, H. S.: Biochemistry and the central nervous system, 4th edn. Edinburgh-London: Churchill Livingstone 1971
Rose, I. A., Warms, J. V. B.: Mitochondrial hexokinase: release, rebinding and location. J. biol. Chem. 242, 1635–1645 (1967)
Tuttle, J. P., Wilson, J. E.: Rat brain hexokinase: A kinetic comparison of soluble and particulate forms. Biochim. biophys. Acta (Amst.) 212, 185–188 (1970)
Wilson, J. E.: The latent hexokinase activity of rat brain mitochondria. Biochem. biophys. Res. Commun. 28, 123–127 (1967)
Wilson, J. E.: Brain hexokinase. J. biol. Chem. 243, 3640–3647 (1968)
Author information
Authors and Affiliations
Additional information
The results have been briefly reported at the 17th spring meeting of the Deutsche Pharmakologische Gesellschaft at Mainz (Krieglstein and Bielicki, 1976)
Rights and permissions
About this article
Cite this article
Bielicki, L., Krieglstein, J. Solubilization of brain mitochondrial hexokinase by thiopental. Naunyn-Schmiedeberg's Arch. Pharmacol. 298, 61–65 (1977). https://doi.org/10.1007/BF00510988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00510988